Cannabidiol (CBD) and Δ9-tetrahydrocannabinol (THC) for chronic insomnia disorder (‘CANSLEEP’ trial): protocol for a randomised, placebo-controlled, double-blinded, proof-of-concept trial
Abstract Introduction: Insomnia is a highly prevalent and costly condition that is associated with increased health risks and healthcare utilisation.…